Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias.
Ouattara
B
B
Molecular Endocrinology and Genomic Research Center, Centre Hospitalier Universitaire de Québec (CHUQ), Pavillon CHUL and Faculty of Pharmacy, Laval University, QC, Canada.
Hoyer
D
D
Grégoire
L
L
Morissette
M
M
Gasparini
F
F
Gomez-Mancilla
B
B
Di Paolo
T
T
D000818:Animals; D000978:Antiparkinson Agents / Q000009:adverse effects*; D001345:Autoradiography; D001583:Benzoxazoles / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D000077465:Cabergoline; D004347:Drug Interactions; D004409:Dyskinesia, Drug-Induced / Q000209:etiology / Q000378:metabolism*; D004873:Ergolines / Q000627:therapeutic use; D005260:Female; D007093:Imidazoles / Q000494:pharmacology; D007980:Levodopa / Q000009:adverse effects*; D008024:Ligands; D020267:MPTP Poisoning / Q000188:drug therapy / Q000378:metabolism*; D008252:Macaca fascicularis; D010880:Piperidines / Q000627:therapeutic use; D011799:Quinazolines / Q000494:pharmacology; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors / Q000378:metabolism*; D017448:Receptors, Dopamine D2 / Q000819:agonists; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors
D000978:Antiparkinson Agents; D001583:Benzoxazoles; D004873:Ergolines; D007093:Imidazoles; D008024:Ligands; D010880:Piperidines; D011799:Quinazolines; D018091:Receptors, AMPA; D017448:Receptors, Dopamine D2; D016194:Receptors, N-Methyl-D-Aspartate; C112933:Ro 48-8587; D007980:Levodopa; C481484:besonprodil; D000077465:Cabergoline